₹ 3.3 Cr
Volume Transacted
(Nov 22, 2024)
26.7 K
Stocks Traded
(Nov 22, 2024)
Last Updated on: Nov 22, 2024
Wockhardt Ltd
NSE: WOCKPHARMA
YEARHIGH
₹ 1334.55
Last updated on: Nov 22, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
No data available
* All values are consolidated
Last Updated time:
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
22 Nov 2024 | 1230.95 | 1171.05 | 1230.95 | 1171 |
21 Nov 2024 | 1172.35 | 1187.95 | 1202.95 | 1152 |
19 Nov 2024 | 1186.95 | 1160 | 1193.3 | 1147.45 |
18 Nov 2024 | 1136.5 | 1161.75 | 1181.2 | 1130 |
14 Nov 2024 | 1170.85 | 1195.45 | 1199.1 | 1149.05 |
13 Nov 2024 | 1190.15 | 1165.9 | 1240.55 | 1133.45 |
12 Nov 2024 | 1181.5 | 1225 | 1236 | 1177 |
11 Nov 2024 | 1222.3 | 1247.95 | 1270 | 1215.35 |
08 Nov 2024 | 1233.85 | 1166 | 1266.75 | 1166 |
07 Nov 2024 | 1206.5 | 1230.95 | 1254 | 1206.5 |
Date | Price (₹) |
---|---|
22 Nov 2024 | 1230.95 |
21 Nov 2024 | 1172.35 |
19 Nov 2024 | 1186.95 |
18 Nov 2024 | 1136.5 |
14 Nov 2024 | 1170.85 |
13 Nov 2024 | 1190.15 |
12 Nov 2024 | 1181.5 |
11 Nov 2024 | 1222.3 |
08 Nov 2024 | 1233.85 |
07 Nov 2024 | 1206.5 |
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Wockhardt Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Wockhardt Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Wockhardt to conduct board meeting
Wockhardt will hold a meeting of the Board of Directors of the Company on 13 November 2024...
08 Nov 202416:42
Wockhardt slumps on launching QIP at discount
The floor price indicates a steep discount of 8.5% over the stock's closing price on Wedne...
07 Nov 202414:38
Wockhardt files its Aspart insulin injection with DCGI
Wockhardt announced the filing of its fast-acting insulin analog, Aspart injection (ASPARA...
16 Oct 202409:21
Wockhardt's once-a-day antibiotic drug 'WCK 6777' successfully concludes Phase I study
Wockhardt is advancing the development of several new antibiotics aimed at combating diffi...
07 Oct 202414:59
Wockhardt announces cessation of director
Wockhardt announced that Tasneem Vikram Singh Mehta (DIN: 05009664) ceased to be Independe...
30 Sep 202418:20
Wockhardt's investigational drug, Zaynich' demonstrates its ability to manage complex infections
In the past year, Wockhardt's investigational drug, Zaynich' (Zidebactam/Cefepime), has su...
19 Sep 202409:15
Unlimited trading at just
Rs. 199*